Vaccination: Clinical Trials

10 trials of Vaccination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 recruiting, 1 terminated. 10 Phase 2, 3 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 5, Unknown 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 13Completed 3
Phase 32Completed 1, Unknown 1

Follow Vaccination: new trials by email Literature Review of Vaccination trials Research Report on Vaccination

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older
Vaccination with rBCG-N-RSV, Vaccination with conventional BCG (BCG-WT) - Respiratory Syncytial Virus Infection Prevention, Tuberculosis Prevention
Phase 2RecruitingBiothervax SpA2002026-09-142026-09-15
Community-based Behavioral Intervention to Increase Vaccination Using MOST
Health education on COVID and flu vaccination, Nurse-led shared decision-making, Text messages - COVID 19, Influenza
Phase 2WithdrawnNew York University2025-04-012025-04-29
A Study of MG1111 in Healthy Children
Varicella Vaccine - Healthy Children
Phase 2 / Phase 3CompletedGreen Cross Corporation8142016-11-262021-05-14
Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease
Vaccination with the combined vaccine (Prevenar13 ®), Vaccination with the polysaccharide vaccine (Pneumo 23 ®) - Invasive Pneumococcal Infections, Sickle Cells Disease
Phase 2CompletedAssistance Publique - Hôpitaux de Paris1162013-09-162022-09-09
A Fmri Study on the Effects of a Conjugate Vaccine and Placebo on CNS Activation and Behavior Following a Nicotine Challenge
vaccination with Nicvax - Nicotine Dependency, Smoking
Phase 1 / Phase 2CompletedMaastricht University Medical Center382011-02-012013-03-04
Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)
vaccination - Esophageal Cancer
Phase 2UnknownUniversity of Yamanashi602010-04-012010-12-28
Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
Vaccination with VZV vaccine - Liver Disease, Immunosuppression
Phase 2 / Phase 3UnknownUniversity Hospital, Geneva802007-06-012020-09-18
Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
LC002 standard vaccination, LC002 high-dose vaccination, LC002 placebo vaccination - HIV Infections
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)282006-01-012021-11-04
Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy
Vaccination - Influenza
Phase 1 / Phase 2CompletedHadassah Medical Organization2002005-10-012006-11-07
Dendritic Cells (DC) Vaccine for Metastatic Melanoma
Vaccination - Metastatic Melanoma
Phase 2TerminatedJohn Kirkwood162002-10-012017-08-16

Conditions studied

Influenza, Human (2)  ·  Anemia, Sickle Cell (1)  ·  COVID-19 (1)  ·  Chickenpox (1)  ·  Esophageal Neoplasms (1)  ·  HIV Infections (1)  ·  Liver Diseases (1)  ·  Melanoma (1)  ·  Smoking (1)  ·  Tuberculosis (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Biothervax SpA (1)  ·  Green Cross Corporation (1)  ·  Hadassah Medical Organization (1)  ·  John Kirkwood (1)  ·  Maastricht University Medical Center (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  New York University (1)  ·  University Hospital, Geneva (1)  ·  University of Yamanashi (1)

Countries

United States (2)  ·  France (1)  ·  Greece (1)  ·  Israel (1)  ·  Japan (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Switzerland (1)

Top investigators

Arie Ben Yehuda, M.D. (1)  ·  Benigno Rodriguez, MD (1)  ·  John M Kirkwood, MD (1)  ·  Klara M Posfay-Barbe, MD, MS (1)  ·  Koji Kono, PhD, MD (1)

Results publications

PMID 24894701, PMID 36705266

NIH funding

2023 (1), P01CA073743 (1)